iNFixion Bioscience
PrivateLast Round
Seed
Mar 3, 2025
Total Funding Raised
$782,804
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iNFixion Bioscience is a biotechnology company that develops gene-targeted therapeutics for the treatment of Neurofibromatosis Type 1.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iNFixion Bioscience Comparables
Compare iNFixion Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healx | 67% | |
| Pasithea Therapeutics Corp. | 64% | |
| AstraZeneca | 64% |
iNFixion Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 3, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Aug 30, 2021 | ||||
| Grant | Jun 25, 2020 |
Key People
Founding team and executive leadership
iNFixion Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Gilbert Family Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 57% MoM.
- Aug 22, 2026
Monthly visitors increased 113% MoM, reaching 1.6K.
iNFixion Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iNFixion Bioscience's valuation, stock price, and market status.
Is iNFixion Bioscience a public or private company?
iNFixion Bioscience is a private company.
What is the current stock price of iNFixion Bioscience?
iNFixion Bioscience is a private company, so its shares have no public market price. Caplight tracks iNFixion Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iNFixion Bioscience worth (valuation)?
Valuation information for iNFixion Bioscience is not publicly available.
Can I buy iNFixion Bioscience stock?
iNFixion Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iNFixion Bioscience's last funding round?
iNFixion Bioscience's most recent funding round was Seed on March 3, 2025.
Who are the main investors in iNFixion Bioscience?
Key investors in iNFixion Bioscience include National Institute of Neurological Disorders and Stroke (NINDS), Gilbert Family Foundation.
Will iNFixion Bioscience IPO soon?
No public IPO plans have been announced for iNFixion Bioscience.
How can I track iNFixion Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in iNFixion Bioscience's shares on secondary markets.